Study Effects of the PRECAPP System on Precarious and Vulnerable Pregnant Women
Launched by CENTRE HOSPITALIER DE SAINT-DENIS · Apr 9, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a program called the PRECAPP System, which aims to support vulnerable pregnant women during their pregnancy and after childbirth. The goal is to understand how well this system helps women navigate their healthcare and avoid interruptions in their care, especially for those who may face challenges due to their circumstances, such as being homeless or having low income. The researchers will look at both data and personal experiences to see if the program improves overall care for these women.
To participate in this study, women must be at least 18 years old and have received care at Gonesse Hospital in 2023. They can be part of the PRECAPP program from early in their pregnancy or may have joined later on, but they must be considered vulnerable in some way. Throughout the study, participants will share their experiences, helping researchers learn how to improve care for all pregnant women in similar situations. It's important to know that this trial is still in the planning stages and has not started recruiting participants yet.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Follow-up in 2023 at Gonesse Hospital
- • Patient having started her PRECAPP follow-up in 2023, between the 2nd and 5th month of pregnancy and having been accompanied throughout her PRECAPP journey (before, during and after childbirth): Classic" PRECAPP pathway
- • Patient with integration (in 2023) of the PRECAPP program late in pregnancy (up to 1 month before delivery): PRECAPP "late" pathway
- • Vulnerable and precarious patient not followed by PRECAPP but who should have been (maternity course completed in 2023): PRECAPP "non-integration" pathway
- Exclusion Criteria:
- • Patient without vulnerability/poverty
- • Patient not followed at the CHG in 2023
About Centre Hospitalier De Saint Denis
The Centre Hospitalier de Saint-Denis is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. Located in Saint-Denis, France, the hospital is renowned for its commitment to patient-centered care, innovative treatments, and interdisciplinary collaboration. As a clinical trial sponsor, it actively engages in the development of new therapeutic options, striving to enhance patient outcomes through rigorous research protocols and adherence to ethical standards. With a focus on diverse medical disciplines, the Centre Hospitalier de Saint-Denis plays a pivotal role in contributing to the advancement of medical knowledge and the improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported